Clinical Trial Update: Efficacy & Safety of Nintedanib in Patients With Progressive Fibrosing Coal Mine Dust-Induced Interstitial Lung Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of nintedanib for progressive fibrosing coal mine dust-induced interstitial lung disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coal Mine Dust-induced Interstitial Lung Disease
• Progressive Fibrosing Interstitial Lung Disease

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: West Virginia University | Conditions: Progressive Fibrosing Interstitial Lung Disease | Phase 3 | Status: WITHDRAWN